A little bit of fairytale, in the world, charged of life prose

Saturday, 22 August 2015 16:20

27-31 of May in Krakow occurred the congress of veterinary oncokogists

In a remarkably beautiful Cracow, whose symbol is a fabulous dragon, from 27 to 31 of May held annually Congress of the European veterinary oncology society (ESVONC). Veterinary specialists interested in questions of Oncology, come not only from Europe but also from other countries of the world - from South Korea to Brazil - to learn on current trends in diagnostics and treatment of patients with neoplasms of various etiology. At the first time, the day before congress, or rather evening, was given for communication with residents of European College of oncology, where Professor Teske discussed with colleagues assessment of scientific publications. Well-known oncologist taugh us to pay attention to details, first of all – the design of investigation ,which previously sliped away of my attention, and subsequently allowing not just blindly trust in the printed word, but also to assess critically the results of many investigations.

The main topic of the first day of Congress was metronomic chemotherapy and the possibilities to effect at microenvironment of neoplasms. There is more and more new information about more extensive utilization of tyrosine kinase-inhibitors, than had planned initially for therapy of mastocytomas. The report of Dr.Rusakievich, in particular, was devoted to immunomodulating effect of imatinib in the stromal neoplasms of gastrointestinal tract. In the report of Dr. Krup were represented facilities of toseranib in therapy of dogs with squamous cell cancer of the head and neck. Usage of monoclonal antibodies is one of the most prospective methods of conservative therapy in modern humane oncology, but this method doesn´t approach for veterinary patients, because of it´s species-specificity and rapid utilization in the organism of dogs and cats. However, reports on the congress apply to usege of monoclonal species-specifity antibodies inspired great optimism. In particular,the report on the use of Dr. Ogilvie antimonoklonal-CD 20 antibodies in combination with conventional chemotherapy in dogs with B-cell lymphoma, audience got to know that this method allowed to increase the survival rate of the patients in half compared with conventional chemotherapy.

The second day of the congress was devoted to this important aspect, as a therapy of pain in patients with cancer, using the various medications to decrease pain and to make lives of dogs and cats with severe and painful tumor states qualitative. Interesting was report og Dr. Pulert about palliative therapy of the pain in patients, suffer from cancer in medical practice.

It arouses the interest of the veterinary oncologists, involved in surgical treatment of patients, report of Dr. Garanina leading surgeons of clinic "Biocontrol" (Moscow), the use of extracorporal irradiated replantats for invariant operations at malignant bone tumors in dogs. Russian colleagues under supervision of M. Yakunina ("Biocontrol") presented a poster report about possibilities of combined gemtsitrabin-doxorubicin chemotherapy in neoadjuvant breast cancer therapy.

On the congress was paid attention of such actual problems, as therapy-resistant lymphoma and opportunities for the treatment of reccurent mast cell tumors with high degree of malignancy.

The final day of the Congress was devoted to the Polish colleagues and become a logical and exciting continuation of ESVONC: a lot of time was devoted to mastotsitomas, and also to histiocytic neoplasms in dogs and cats. For doctors who have extensive surgical practice, were very useful reports of Dr. Kessler, relating reconstructive plastic surgery after the construction of sweeping operations in patients with malignant neoplastic processes. The operative treatment of thyroid and parathyroid glands´ tumors - the report of Dr. Johan de Vos - caused a bright discussion even after the end of the section. Dr. Adrian Krupa stoped in detail on this widespread diseases as perianal tumors, paying a lot of attention on all possible methods of therapy.

Polish colleagues, who accepted in their country oncologists from all over world, have done everything possible to creating a unique atmosphere, giving guests the opportunity to acquaint with pearl of Malopolska without missing any day of the Congress. Thus, the opening ceremony was held in National Gallery among masterpieces of Polish art, and for the dinner, the guests went down to a depth of 89 meters in the amazing salt mines of Wieliczko, which are subject of UNESCO World Heritage Site.nBallrooms, sculptures, bas-liefs, chandeliers - everything was done of salt, and it was breathe-taking. It is difficult to overestimate the importance and of informal communication,where among the exchange of experience with collective often find answers to long tormented you questions.

I would like to thank the organizators of ESVONC Congress and personally Tom Hendricks, president of the European society of veterinary Oncology (ESVONC), for possibility of participation in such significant for anyone interested in veterinary oncology event, admire the Polish colleagues, who can to approach the fairytale and create a unique atmosphere of magic. And all, eho interesting in actual problems of diagnostics and treatment of oncological patients, I want to wish to prepare for Second Universal Veterinary Oncological Congress, which will be in Brazil, in the picturesque Foz-do-Iguacu in 26-29 May 2016.

Last modified on Saturday, 22 August 2015 16:22
Rate this item
(0 votes)
Read 1086 times

Login

Who's online

We have 258 guests and no members online

Where we are:

loading map...
Click item below to move to